PESCINI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 4.036
EU - Europa 2.676
AS - Asia 1.906
SA - Sud America 166
AF - Africa 41
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.855
Nazione #
US - Stati Uniti d'America 3.979
RU - Federazione Russa 1.010
SG - Singapore 565
CN - Cina 504
PL - Polonia 466
IT - Italia 365
HK - Hong Kong 264
SE - Svezia 207
IE - Irlanda 202
VN - Vietnam 198
KR - Corea 135
BR - Brasile 131
FR - Francia 101
DE - Germania 88
FI - Finlandia 85
GB - Regno Unito 63
IN - India 63
CA - Canada 38
JO - Giordania 36
AU - Australia 28
JP - Giappone 28
TR - Turchia 21
UA - Ucraina 20
AR - Argentina 18
ID - Indonesia 17
BD - Bangladesh 16
ES - Italia 16
NL - Olanda 16
IQ - Iraq 12
CI - Costa d'Avorio 11
MX - Messico 11
ZA - Sudafrica 9
CZ - Repubblica Ceca 7
AE - Emirati Arabi Uniti 6
BE - Belgio 6
LT - Lituania 6
MA - Marocco 6
CL - Cile 4
EC - Ecuador 4
RO - Romania 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
CO - Colombia 3
CR - Costa Rica 3
EG - Egitto 3
MY - Malesia 3
OM - Oman 3
PK - Pakistan 3
PS - Palestinian Territory 3
SN - Senegal 3
VE - Venezuela 3
AL - Albania 2
BH - Bahrain 2
BY - Bielorussia 2
GR - Grecia 2
HN - Honduras 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
NG - Nigeria 2
NP - Nepal 2
PH - Filippine 2
PT - Portogallo 2
PY - Paraguay 2
TN - Tunisia 2
TW - Taiwan 2
AM - Armenia 1
AZ - Azerbaigian 1
BB - Barbados 1
BO - Bolivia 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
KN - Saint Kitts e Nevis 1
LB - Libano 1
LY - Libia 1
ML - Mali 1
MN - Mongolia 1
MT - Malta 1
QA - Qatar 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.855
Città #
Santa Clara 712
Ashburn 511
Warsaw 466
Singapore 372
Fairfield 348
Chandler 235
Hong Kong 222
Dublin 202
Woodbridge 184
Houston 144
San Jose 139
Seattle 139
Beijing 137
Seoul 135
Cambridge 134
Wilmington 116
Florence 88
Ho Chi Minh City 77
Hefei 75
Altamura 70
Lawrence 67
Los Angeles 63
Princeton 58
Ann Arbor 57
Moscow 50
Lauterbourg 47
The Dalles 46
Buffalo 45
Jacksonville 44
Paris 41
New York 40
Boston 37
Hanoi 37
Mumbai 36
Munich 36
Melbourne 28
Tokyo 27
Shanghai 26
Council Bluffs 25
Turku 24
Medford 23
Helsinki 22
Kent 20
Boardman 19
Dallas 18
London 18
San Diego 18
Clifton 15
Toronto 15
Izmir 14
Orem 13
Denver 12
São Paulo 12
Abidjan 11
Chicago 11
Jakarta 11
Milan 11
Rome 11
Falls Church 10
Frankfurt am Main 10
Guangzhou 10
Montreal 10
Redondo Beach 10
Chennai 9
Johannesburg 9
Norwalk 9
Phoenix 9
Barcelona 7
Da Nang 7
Dong Ket 7
Manchester 7
Yubileyny 7
Andover 6
Atlanta 6
Brno 6
Brooklyn 6
Dearborn 6
Hillsboro 6
Lappeenranta 6
Poplar 6
Stockholm 6
Baghdad 5
Biên Hòa 5
Cantù 5
Falkenstein 5
Hải Dương 5
Shenzhen 5
Amsterdam 4
Belo Horizonte 4
Bengaluru 4
Brasília 4
Cagliari 4
Chiesina Uzzanese 4
Detroit 4
Guarulhos 4
Haiphong 4
Hounslow 4
Tashkent 4
Verona 4
Zhengzhou 4
Totale 5.871
Nome #
Caratteristiche cliniche, profilo di rischio vascolare e profilo neuropsicologico dei pazienti affetti da leucoencefalopatia micro vascolare sporadica (età-correlata) e geneticamente determinata (CADASIL): Risultati preliminari del MIcrovascular LEukoencephalopaty Study (MILES) 278
CEREBRAL AUTOREGULATION IN THE EARLY STAGES OF CADASIL (CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY) 258
Operationalizing mild cognitive impairment criteria in small vessel disease: The VMCI-Tuscany Study 250
Syncope and Epilepsy coexist in 'possible' and 'drug-resistant' epilepsy (Overlap between Epilepsy and Syncope Study - OESYS) 241
Reperfusion Injury after ischemic Stroke Study (RISKS): Single-centre (Florence, Italy), prospective observational protocol study 240
Role of biological markers for cerebral bleeding risk STRATification in patients with atrial fibrillation on oral anticoagulants for primary or secondary prevention of ischemic stroke (Strat-AF study): Study design and methodology 226
Cerebral microbleeds in patients with mild cognitive impairment and small vessel disease: The Vascular Mild Cognitive Impairment (VMCI)-Tuscany study 213
Diffusion Tensor Imaging to Map Brain Microstructural Changes in CADASIL 203
Circulating Biomarkers in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy Patients 200
Can CHA2DS2-VASc and HAS-BLED Foresee the Presence of Cerebral Microbleeds, Lacunar and Non-Lacunar Infarcts in Elderly Patients With Atrial Fibrillation? Data From Strat-AF Study 195
APOE ε 2 is associated with white matter hyperintensity volume in CADASIL 195
The serum metabolomic profiles of atrial fibrillation patients treated with direct oral anticoagulants or vitamin K antagonists 190
Acetazolamide for the prophylaxis of migraine in CADASIL: a preliminary experience. 190
CADASIL in central Italy: A retrospective clinical and genetic study in 229 patients 183
Bone marrow-derived progenitor cells in cerebral autosomal dominantarteriopathy with subcortical infarcts and leukoencephalopathy 182
Mild cognitive impairment etiologic subtyping using pragmatic and conventional criteria: preliminary experience in the Florence VAS-COG clinic. 181
Longitudinal changes in MoCA performances in patients with mild cognitive impairment and small vessel disease. Results from the VMCI-Tuscany Study 179
Cerebellar arteriovenous malformation and vertebral artery aneurysm in a CADASIL patient 173
The CADASIL scale: a screening tool to select patients for NOTCH3 gene analysis 173
A pathogenic mutation on exon 21 of the NOTCH3 gene causing CADASIL in an octogenarian paucisymptomatic patient 172
Association Between Motor and Cognitive Performances in Elderly With Atrial Fibrillation: Strat-AF Study 170
European Stroke Organisation Conference: Abstracts 169
White matter microstructural damage and depressive symptoms in patients with mild cognitive impairment and cerebral small vessel disease: the VMCI-Tuscany Study. 168
Intravenous thrombolysis in CADASIL: report of two cases and a systematic review 165
Cognitive phenotypes and factors associated with cognitive decline in a cohort of older patients with atrial fibrillation: The Strat-AF study 164
Blood–brain barrier leakage and hemorrhagic transformation: The Reperfusion Injury in Ischemic StroKe (RISK) study 163
A pathogenic mutation on exon 21 of the NOTCH3 gene causing CADASIL in an octogenarian paucisymptomatic patient 160
Application of the DSM-5 Criteria for Major Neurocognitive Disorder to Vascular MCI Patients 156
Influence of vascular risk factors and neuropsychological profile on functional performances in CADASIL: results from the MIcrovascular LEukoencephalopathy Study (MILES). 156
Coronary microvascular function is impaired in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy 156
Differential diagnosis between epilepsy and syncope. The Oesys study (overlapping between epilepsy and syncope study): Preliminary results 154
The contribution of cerebrospinal fluid oligoclonal band sto the early diagnosis of multiple sclerosis 153
Thrombophilic risk factors and unusual clinical features in three Italian CADASIL patients 151
High lipoprotein(a) serum levels in three CADASIL families. 150
Familial cerebral cavernous malformation: report of a further Italian family 148
Cerebral hemorrhages in CADASIL: report of four cases and a brief review. 144
Ischemic stroke during cisplatin-based chemotherapy for testicular germ celltumor: case report and review of the literature. 143
Association of nimodipine and choline alphoscerate in the treatment of cognitive impairment in patients with cerebral small vessel disease: study protocol for a randomized placebo-controlled trial—the CONIVaD trial 142
Stroke recurrence in an elderly CADASIL patient on aspirin discontinuation due to severe auto-immune thrombocytopenia 136
Cardiac calcified amorphous tumor as a rare cause of ischemic stroke: Clinical case 136
Functional Magnetic Resonance Imaging of Inhibitory Control Reveals Decreased Blood Oxygen Level Dependent Effect in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy 135
Efficacy and Safety of the Association of Nimodipine and Choline Alphoscerate in the Treatment of Cognitive Impairment in Patients with Cerebral Small Vessel Disease. The CONIVaD Trial 132
Detection of subclinical atrial fibrillation after cryptogenic stroke using implantable cardiac monitors 132
Altered Regional Brain Homogeneity of BOLD Signal in CADASIL: A Resting State fMRI Study 128
Letter by Pescini et al Regarding Article, "Peripheral Artery Disease as a Manifestation of Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) and Practical Implications". 125
Postpartum psychiatric disturbances as an unrecognized onset of CADASIL. 124
Psychiatric disturbances in CADASIL: a brief review 122
Mutation screening of HTRA1 gene in NOTCH3-negative patients with cerebral small vessel disease 121
Exploring differences in Cerebral Small Vessel Disease: a comparative analysis of clinical, radiological and cognitive features of Cerebral Amyloid Angiopathy and Deep Perforator Arteriopathy 117
High frequency of exon 10 mutations in the NOTCH3 gene in Italian CADASIL families: phenotypic peculiarities. 114
Response to letter regarding article, “The cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy scale. A screening tool to select patients for NOTCH3 gene analysis” 110
Effects of sapropterin on endothelium-dependent vasodilation in patients with CADASIL: a randomized controlled trial 109
First report of a Romanian CADASIL patient following immigration to Italy 105
Genome-wide genotyping demonstrates a polygenic risk score associated with white matter hyperintensity volume in CADASIL 101
Pleiotropic Effects of Oral Anticoagulant Therapy: Is There a Difference Between VKAs and DOACs? 19
Disease Severity Staging System for NOTCH3-Associated Small Vessel Disease, Including CADASIL 16
A single-blind randomized trial on the efficacy of telerehabilitation in post-stroke cognitive impairment. CIPS-TER study: rationale, design and methodology 13
Totale 8.929
Categoria #
all - tutte 26.020
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.020


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202169 0 0 0 0 0 0 0 0 0 0 29 40
2021/2022295 11 24 12 8 5 27 11 24 11 19 44 99
2022/2023994 91 227 42 64 71 164 122 48 104 2 46 13
2023/2024407 11 40 58 19 40 51 14 99 6 22 25 22
2024/20252.560 100 321 161 421 620 300 43 183 110 82 90 129
2025/20262.598 369 401 185 242 386 103 338 134 157 204 79 0
Totale 8.929